Works about ANTHRACYCLINES

Results: 2312
    1

    Alternative mRNA splicing in anthracycline-induced cardiomyopathy – a COG-ALTE03N1 report.

    Published in:
    Cardio-Oncology, 2025, v. 11, n. 1, p. 1, doi. 10.1186/s40959-025-00345-2
    By:
    • Singh, Purnima;
    • Crossman, David K.;
    • Cheng, Changde;
    • Trainor, Patrick J.;
    • Sharafeldin, Noha;
    • Wang, Xuexia;
    • Zhou, Liting;
    • Hageman, Lindsey;
    • Armenian, Saro H.;
    • Balis, Frank M.;
    • Hawkins, Douglas S.;
    • Keller, Frank G.;
    • Hudson, Melissa M.;
    • Neglia, Joseph P.;
    • Ginsberg, Jill P.;
    • Landier, Wendy;
    • Bhatia, Smita
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12

    Imatinib mesylate in thymic epithelial malignancies.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 2, p. 309, doi. 10.1007/s00280-011-1690-0
    By:
    • Palmieri, Giovannella;
    • Marino, Mirella;
    • Buonerba, Carlo;
    • Federico, Piera;
    • Conti, Salvatore;
    • Milella, Michele;
    • Petillo, Luigi;
    • Evoli, Amelia;
    • Lalle, Maurizio;
    • Ceribelli, Anna;
    • Merola, Gerardina;
    • Matano, Elide;
    • Sioletic, Stefano;
    • Placido, Sabino;
    • Di Lorenzo, Giuseppe;
    • Damiano, Vincenzo
    Publication type:
    Article
    13
    14

    Triple-negative phenotype is of adverse prognostic value in patients treated with dose-dense sequential adjuvant chemotherapy: a translational research analysis in the context of a Hellenic Cooperative Oncology Group (HeCOG) randomized phase III trial.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 2, p. 533, doi. 10.1007/s00280-011-1730-9
    By:
    • Skarlos, P.;
    • Christodoulou, C.;
    • Kalogeras, K.;
    • Eleftheraki, A.;
    • Bobos, M.;
    • Batistatou, A.;
    • Valavanis, C.;
    • Tzaida, O.;
    • Timotheadou, E.;
    • Kronenwett, R.;
    • Wirtz, R.;
    • Kostopoulos, I.;
    • Televantou, D.;
    • Koutselini, E.;
    • Papaspirou, I.;
    • Papadimitriou, C.;
    • Pectasides, D.;
    • Gogas, H.;
    • Aravantinos, G.;
    • Pavlidis, N.
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32

    Phase II study of capecitabine and trastuzumab combination chemotherapy in patients with HER2 overexpressing metastatic breast cancers resistant to both anthracyclines and taxanes.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 2, p. 361, doi. 10.1007/s00280-008-0882-8
    By:
    • Ishida, Takanori;
    • Kiba, Takayoshi;
    • Takeda, Motohiro;
    • Matsuyama, Kotone;
    • Teramukai, Satoshi;
    • Ishiwata, Ryota;
    • Masuda, Norikazu;
    • Takatsuka, Yuichi;
    • Noguchi, Shinzaburo;
    • Ishioka, Chikashi;
    • Fukushima, Masanori;
    • Ohuchi, Noriaki
    Publication type:
    Article
    33
    34
    35
    36
    37

    Impact of celecoxib on capecitabine tolerability and activity in pretreated metastatic breast cancer: results of a phase II study with biomarker evaluation.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 4, p. 717, doi. 10.1007/s00280-007-0650-1
    By:
    • Fabi, Alessandra;
    • Metro, Giulio;
    • Papaldo, Paola;
    • Mottolese, Marcella;
    • Melucci, Elisa;
    • Carlini, Paolo;
    • Sperduti, Isabella;
    • Russillo, Michelangelo;
    • Gelibter, Alain;
    • Ferretti, Gianluigi;
    • Tomao, Silverio;
    • Milella, Michele;
    • Cognetti, Francesco
    Publication type:
    Article
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50